Jun 11, 2020
Bio-Techne And ZERO - The End Of Prostate Cancer Announce Partnership To Fund Education And Awareness Campaigns To Empower Men With Prostate Cancer
May 21, 2020
Dr. David Samadi of RoboticOncology helps professional baseball icon Jose Offerman defeat prostate cancer using robotic prostate surgery in Dominican Republic
May 07, 2020
Bio-Techne Announces Publication of ExoDx(TM) Prostate (IntelliScore) EPI Test Clinical Utility Study
May 05, 2020
U.S. and Canada Prostate Cancer Diagnostics & Therapeutics Markets, 2020 Report
Apr 15, 2020
Bio-Techne's Exosome Diagnostics Launches ExoDx Prostate At-Home Collection Kit
Jan 08, 2020
Accuray CyberKnife® System Provides Excellent Disease Control for Men with Recurrent Prostate Cancer, a Medical Condition with Few Viable Treatment Options
Dec 02, 2019
Novel MRI-Guided Ultrasound Treatment Destroys Prostate Cancer
Dec 02, 2019
Stratify Genomics announces Hispanic validation of Prompt PGS test for lifetime risk of prostate cancer
Nov 27, 2019
The global cancer biomarkers market is expected to reach US$ 31,206.00 Mn in 2027 from US$ 12,175.69 in 2018
Nov 25, 2019
Stratify Genomics partners with PWNHealth to deliver groundbreaking service to online customers
Nov 14, 2019
Trovagene Presents Positive Data in Metastatic Prostate Cancer Phase 2 Trial Showing Clinical Response in Patients Resistant to Zytiga®
Oct 29, 2019
RhoVac Receives Approval in Finland to Start Clinical Phase IIb Study in Prostate Cancer
Oct 17, 2019
Prostate Cancer Diagnostics and Minimally Invasive Treatments Markets, 2023
Oct 10, 2019
Medicare Issues Final Local Coverage Decision For Bio-Techne's ExoDx(TM) Prostate(IntelliScore) Test
Oct 10, 2019
Urology Specialists of Maryland at Mercy Medical Center Now Offers Patients MRI TRUS Fusion Biopsy
Oct 03, 2019
Global Prostate Cancer Diagnostics and Minimally Invasive Treatments Report 2019: Epidemiology, Leading Treatments, Competitive Analysis, Market Dynamics, Five Year Forecasts
Oct 02, 2019
Theragnostics Reports Positive Clinical Trial Results from Prostate Cancer Study
Aug 06, 2019
New Test Capable of Detecting Clinically Significant Prostate Cancer in Small Blood Sample
Jun 04, 2019
Nanostics Announces Launch of its Clinical Validation Study for ClarityDX Prostate
May 30, 2019
Published Study Demonstrates Feasibility of a Blood Test to Predict Disease Progression and Metastasis in Localized Prostate Cancer